-
Something wrong with this record ?
U koho, kdy a jak upravovat srdeční frekvenci při fibrilaci síní
[Who, when and how to rate control for atrial fibrillation]
Michiel Rienstra, Isabelle C. Van Gelder
Language Czech Country Czech Republic
- MeSH
- Anti-Arrhythmia Agents therapeutic use MeSH
- Atrial Fibrillation drug therapy surgery therapy MeSH
- Cardiac Pacing, Artificial MeSH
- Catheter Ablation MeSH
- Humans MeSH
- Atrioventricular Node surgery MeSH
- Patient Selection MeSH
- Check Tag
- Humans MeSH
The aim of this review is to provide a perspective on rate control in atrial fibrillation, in the era after the large randomized trials comparing rate and rhythm control. This review emphasizes the indications for rate control, the optimal heart rate and the different treatment modalities. RECENT FINDINGS: Large studies have shown that rate control is not inferior to rhythm control with regard to cardiovascular morbidity and mortality. Rate control may now be instituted earlier during the course of the disease, even as first-choice therapy in some patients, particularly those with hypertension and underlying heart diseases, and those who are not (severely) symptomatic. The goals of rate-control therapy are to reduce symptoms, improve quality of life, minimize the development of heart failure, and prevent thromboembolic complications. An important negative aspect of rate-control therapy is the side effects of drugs. The optimal heart rate during atrial fibrillation has not yet been carefully investigated. Several approaches to control rate during atrial fibrillation are available, including pharmacological rate control and atrioventricular nodal ablation with pacemaker implantation. SUMMARY: Understanding the indications for rate control, treatment goals and options will gain the largest benefit for the individual patient with atrial fibrillation.
Who, when and how to rate control for atrial fibrillation
Lit.: 42
- 000
- 02961naa 2200385 a 4500
- 001
- bmc07506299
- 003
- CZ-PrNML
- 005
- 20111210122551.0
- 008
- 080704s2008 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Rienstra, Michiel
- 245 10
- $a U koho, kdy a jak upravovat srdeční frekvenci při fibrilaci síní / $c Michiel Rienstra, Isabelle C. Van Gelder
- 246 11
- $a Who, when and how to rate control for atrial fibrillation
- 314 __
- $a Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen
- 504 __
- $a Lit.: 42
- 520 9_
- $a The aim of this review is to provide a perspective on rate control in atrial fibrillation, in the era after the large randomized trials comparing rate and rhythm control. This review emphasizes the indications for rate control, the optimal heart rate and the different treatment modalities. RECENT FINDINGS: Large studies have shown that rate control is not inferior to rhythm control with regard to cardiovascular morbidity and mortality. Rate control may now be instituted earlier during the course of the disease, even as first-choice therapy in some patients, particularly those with hypertension and underlying heart diseases, and those who are not (severely) symptomatic. The goals of rate-control therapy are to reduce symptoms, improve quality of life, minimize the development of heart failure, and prevent thromboembolic complications. An important negative aspect of rate-control therapy is the side effects of drugs. The optimal heart rate during atrial fibrillation has not yet been carefully investigated. Several approaches to control rate during atrial fibrillation are available, including pharmacological rate control and atrioventricular nodal ablation with pacemaker implantation. SUMMARY: Understanding the indications for rate control, treatment goals and options will gain the largest benefit for the individual patient with atrial fibrillation.
- 650 _2
- $a antiarytmika $x terapeutické užití $7 D000889
- 650 _2
- $a fibrilace síní $x farmakoterapie $x chirurgie $x terapie $7 D001281
- 650 _2
- $a nodus atrioventricularis $x chirurgie $7 D001283
- 650 _2
- $a kardiostimulace umělá $7 D002304
- 650 _2
- $a katetrizační ablace $7 D017115
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a výběr pacientů $7 D018579
- 700 1_
- $a Van Gelder, Isabelle C.
- 773 0_
- $w MED00156016 $t Current opinion in cardiology $g Roč. 2, č. 1 (2008), s. 21-25 $x 1802-3711
- 910 __
- $a ABA008 $b B 2480 $c 414 $y 1
- 990 __
- $a 20080704081217 $b ABA008
- 991 __
- $a 20080708085810 $b ABA008
- 999 __
- $a ok $b bmc $g 621925 $s 474358
- BAS __
- $a 3
- BMC __
- $a 2008 $b 2 $c 1 $d 21-25 $i 1802-3711 $m Current opinion in cardiology (České vyd.) $x MED00156016
- LZP __
- $a 2008-7/mkme